Patents for C07C 255 - Carboxylic acid nitriles (27,066) |
---|
05/27/2004 | US20040102318 Method for enhancing the productivity of vanadium antimony oxide catalysts |
05/27/2004 | US20040100188 Anthracene derivative and organic electroluminescence device using the derivative |
05/27/2004 | CA2765093A1 Bicyclic-substituted amines as histamine-3 receptor ligands |
05/27/2004 | CA2505098A1 Phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease |
05/26/2004 | EP1421634A2 Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives |
05/26/2004 | EP1421069A1 Process for the preparation of cyclopenta[g]quinazoline derivatives |
05/26/2004 | EP1421058A2 Processes for the production of alpha-difluoromethyl ornithine (dfmo) |
05/26/2004 | EP1248767B1 Separation of the products of polyamide ammonolysis |
05/26/2004 | EP1064255B1 A process for the manufacture of (2s,2'r,3'r)-2-(2,3-dicarboxylcyclopropyl)-glycine |
05/26/2004 | EP0935691B1 Optical brightening agent |
05/26/2004 | CN1151123C Acetonitrile refining and recovering process |
05/25/2004 | US6740769 Controlling particle diameter; ammoxidation production of acrylonitrile or methacrylonitrile |
05/25/2004 | US6740765 Decarboxylating diester |
05/25/2004 | US6740682 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury. |
05/25/2004 | US6740620 Orthorhombic phase mixed metal oxide of vanadium, molybdenum and/or tungsten, one of tellurium and selenium, and at least one other element; oxidation catalysts for production of acrylic acid or acrylonitrile |
05/25/2004 | CA2048172C Substituted sulfonamids, preparation processes and drugs containing same |
05/21/2004 | WO2004041774A1 Aromatic amine derivative and organic electroluminescent element employing the same |
05/21/2004 | WO2004041266A1 Receptor function controlling agent |
05/21/2004 | WO2004005406A3 Charge transport compositions on the basis of triarylmethanes and their use in electronic devices |
05/21/2004 | WO2003000652A8 Process for preparation of cyclohexanol derivatives |
05/21/2004 | CA2505322A1 Receptor function regulator |
05/20/2004 | US20040097754 Three-dimensional catalyst support structure carrying reducible metal oxide with a Group 8 promoter metal; preparing a carboxylic acid or nitrile by adding an additional catalyst and oxygen source or ammonia |
05/20/2004 | US20040097725 Charge transport compositions and electronic devices made with such compositions |
05/20/2004 | US20040097675 Simple, fast synthesis of nitrile monomers; terpolymers including such as 5,6,6-trifluoro-5-hexene nitrile and perfluoro(4-methyl-3,6-dioxaoct-7-ene)sulphonyl fluoride |
05/20/2004 | US20040097547 For therapy of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer |
05/20/2004 | US20040097499 Useful for potentiating glutamate receptor function in a mammal and therefore, useful for treating a wide variety of conditions, such as psychiatric and neurological disorders |
05/19/2004 | EP1420011A1 Compounds usefulfor treating allergic and inflammatory diseases |
05/19/2004 | EP1419152A1 Hiv inhibiting pyrimidines derivatives |
05/19/2004 | EP1419141A1 Stabilisation of ethylenically-unsaturated compounds with amidoximes |
05/19/2004 | EP1419140A1 Improved operation of heads column in acrylonitrile production |
05/19/2004 | EP1419139A1 Synthesis of unsaturated nitriles from lactones |
05/19/2004 | EP1418950A1 Solid-phase nucleophilic fluorination |
05/19/2004 | EP1418900A1 Selective estrogen receptor modulators |
05/19/2004 | EP1418879A1 Oxidation hair dyes containing 3-aminophenol derivatives, and novel 3-aminophenol derivatives |
05/19/2004 | EP1095932B1 Phenoxyacetic acid derivatives and medicinal compositions containing the same |
05/19/2004 | EP0717736B1 Phosphorus derivatives to treat aids |
05/19/2004 | DE10251680A1 Verfahren zur CaO-katalysierten Herstellung von Isophoronnitril Process for the CaO-catalyzed production of isophoronenitrile |
05/19/2004 | DE10250743A1 Neue Amid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New amide compounds with MCH-antagonistic activity and pharmaceutical compositions containing them |
05/19/2004 | CN1498205A Aryl and biaryl compounds having MCH modulatory activity |
05/19/2004 | CN1150161C Non-steroidal ligands for estrogen receptor |
05/18/2004 | US6737550 Lithium salt of 4- fluorophenyl methyl sulfone as the chemical intermediate; drug with antiandrogen activity |
05/18/2004 | US6737540 Aminonitrile production |
05/18/2004 | US6737539 Selective production of such as adiponitrile |
05/18/2004 | CA2130915C Purification of 6-aminocapronitrile |
05/18/2004 | CA2122254C The resolution of racemic verapamil |
05/13/2004 | WO2004040534A2 Metal chelates and methods of using them for time-resolved fluorescence |
05/13/2004 | WO2004039764A1 Novel amide compounds with mch antagonistic effect and medicaments comprising said compounds |
05/13/2004 | WO2004026812A3 Method for catalyst-free production of cyanophenols from methoxybenzonitriles |
05/13/2004 | WO2003070666A3 Process for making organic products from non-product streams using phase transfer catalysis |
05/13/2004 | US20040092761 CaO-catalyzed preparation of isophoronenitrile |
05/13/2004 | US20040092687 Polymeric charge transport compositions and electronic devices made with such compositions |
05/13/2004 | US20040092598 Antiproliferative agnets; anticancer agents; skin disorders |
05/13/2004 | US20040092593 Hypotensive agents; cardiovascular disorders |
05/13/2004 | US20040092553 Excitatory amino acid receptor modulators |
05/13/2004 | US20040092517 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours |
05/13/2004 | US20040089845 Phenylcyclohexanes and a liquid-crystalline medium |
05/13/2004 | DE10249339A1 Verfahren zur Racematspaltung von 3-Aminopentannitril Procedures for the resolution of 3-aminopentanenitrile |
05/13/2004 | CA2502959A1 Metal chelates and methods of using them for time-resolved fluorescence |
05/12/2004 | EP1418172A2 Process for CaO catalysed preparation of isophorone nitrile |
05/12/2004 | EP1417169A2 Selective estrogen receptor modulators |
05/12/2004 | EP1289938B1 A process for the preparation of 2,2-dimethyl-5-(4-clorobenzyl) cyclopentanone and an intermediate useful therefor |
05/12/2004 | EP1263713B1 Process for the carbonylation of pentenenitrile |
05/12/2004 | EP1263709B1 Process for the carbonylation of ethylenically unsaturated compounds |
05/12/2004 | EP1196375B1 Solid phase nitrile synthesis |
05/12/2004 | EP1163208B1 Caspase inhibitors and uses thereof |
05/12/2004 | EP1024139B1 Process for the preparation of optically active 2-(6-(hydroxymethyl)-1,3-dioxan-4-yl) acetic acid derivatives |
05/12/2004 | EP0996616B1 Process and a novel intermediate for the preparation of flecainide |
05/12/2004 | EP0923371B1 Pharmaceutical compositions comprising tyrphostins |
05/12/2004 | CN1495168A Intermediate for preparing pesticide |
05/12/2004 | CN1495167A New preparation method of pesticide intermediate |
05/12/2004 | CN1495158A Intermediate for preparing isoxazolinyl-3-acylbenzene and process for preparing said intermediate |
05/11/2004 | US6734203 Fused imidazolium derivatives |
05/11/2004 | US6734136 IR and/or SM promoted multi-metal oxide catalyst |
05/11/2004 | US6733693 Acrylonitrile solutions of maleimides, method for preparation thereof, and acrylonitrile based copolymers obtained by use of the solutions |
05/11/2004 | US6733690 Acrylic ester polymers |
05/11/2004 | CA2316821C Method for regenerating a hydrogenation catalyst, method for hydrogenating compounds comprising nitrile functions |
05/11/2004 | CA2279428C Compounds and methods for therapeutic intervention in preventing diabetic complications |
05/06/2004 | WO2004037751A2 Aryl and heteroaryl propene amides, derivatives thereof and therapeutic uses thereof |
05/06/2004 | WO2004037399A2 Multiphasic microchannel reactions |
05/06/2004 | WO2004037181A2 Glycinenitrile-based inhibitors of dipeptidyl peptidase iv and methods |
05/06/2004 | WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
05/06/2004 | US20040087811 Process for the racemate resolution of 3-aminopentanenitrile |
05/06/2004 | US20040087590 Novel biphenyl and biphenyl-like cannabinoids |
05/06/2004 | EP1415981A1 Aminonitrile production |
05/06/2004 | EP1414778A1 Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. |
05/06/2004 | EP1414569A2 Optically active catalysts comprising salen ligands and vanadium(iv), their preparation and use in the production of cyanhydrines |
05/06/2004 | EP1414567A1 Catalyst system containing ni(0) for hydrocyanation |
05/06/2004 | EP1326836B1 Process for making 3-amino-2-chloro-4-methylpyridine |
05/06/2004 | DE10250254A1 Deodorizing aqueous solutions of cationic acetonitrile derivatives useful as bleach activators comprises treatment with a percarboxylic acid, a carboxylic acid and hydrogen peroxide |
05/06/2004 | DE10247966A1 5,7,7-Trimethyloctannitril 5,7,7-trimethyloctanenitrile |
05/06/2004 | CA2497060A1 Aryl and heteroaryl propene amides, derivatives thereof and therapeutic uses thereof |
05/05/2004 | CN1148345C Process for producing hexaminocapronitrile and/or hexamethylenediamine |
05/05/2004 | CN1148257C Catalysts for ammoxidation of alkanes |
05/04/2004 | US6730809 Processes for the production of α-difluoromethyl ornithine (DFMO) |
05/04/2004 | US6730803 Production method of a beta -keto ester compound of claim 1, which comprises condensation of a 2-cyano-2,2-dimethylacetate solution to give 2-cyano-2,2- dimethylacetate of the formula (ii), and condensation thereof |
05/04/2004 | US6730705 Alkoximino acetic acid amides |
04/29/2004 | WO2004035736A2 Halogenated selective androgen receptor modulators and methods of use thereof |
04/29/2004 | WO2004035526A1 Process for producing aromatic nitrile compound |
04/29/2004 | WO2004006354A3 Polymeric charge transport compositions and electronic devices made with such compositions |
04/29/2004 | WO2003009807A3 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |